SANTA CLARA, Calif. & SHENZHEN, China--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) and BGI today announced a collaborative effort to develop methodologies designated for next-generation genome-wide association studies. The methodologies will assist scientists pursuing disease and drug research.
